Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
When To Diversify Beyond Indices offers criteria and steps to broaden exposure beyond benchmarks, reducing risk and potentially improving returns.
20,072 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Schd’s $71.6 billion portfolio has posted a 20% year-to-date price gain alongside a 3.3% yield, underscoring the appe...
Jim Cramer won’t touch POET as retail investors drive a volatile rally. This report tracks the catalysts, the bets, a...
As Okta gears up for 2027 earnings, investors weigh big growth bets against profitability hurdles. This guide breaks ...
Girls Who Code CEO Tarika Barrett says 70% of teen girls want cybersecurity careers, but a weak pipeline threatens a ...
A sudden setback from a key launch partner has jolted AST SpaceMobile investors. This guide explains the causes, pote...
A recent SEC filing shows Pale Fire Capital expanding its Ziff Davis position. This move offers clues about hedge fun...
Stride stock has fallen significantly over the last year. This article digs into the reasons behind the decline and e...
SpaceX’s latest IPO disclosures raise a rare self‑awareness moment: its own push for a crowded Low Earth Orbit could ...
Ethereum remains well below its 4,950 peak as staking grows and institutional attention returns. Market watchers weig...
Meta is betting big on subscriptions with Meta One to pair recurring revenue with AI capability. The thing investors ...
A new defense AI initiative is rattling markets and family budgets as lawmakers weigh safeguards. A senior official w...